Patent · US Active

Expression vector for cholesterol 24-hydrolase in therapy of Huntington's disease

US9132173B2 · kind B2 · utility

1Cited by

1References

13Claims

0Family size

Assignees

Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
UNIVERSITE DE PARIS DESCARTES · FR
UNIVERSITE D'EVRY VAL D'ESSONNE · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR

Inventors

Jocelyne Caboche · Vicq, FR
Patrick Aubourg · Granville, US
Nathalie Cartier · Paris, FR
Sandrine Betuing · Paris, FR

Key dates

Filing date	Oct 14, 2011
Grant date	Sep 15, 2015
Priority date	—
Expiry date	Jun 30, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2840/203
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a vector for use in the treatment of Huntington's disease, which vector comprises a cholesterol 24-hydroxylase encoding nucleic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.